Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Participant Database for Autism Research Studies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Massachusetts General Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Martha Herbert, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00549731
First received: October 15, 2007
Last updated: May 31, 2013
Last verified: April 2012

October 15, 2007
May 31, 2013
June 2005
January 2014   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00549731 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Participant Database for Autism Research Studies
Participant Database for Persons Interested in Autism Research Studies: Recruiting, Pre-Screening and Diagnostic Assessment

The purpose of this study is to create a subject database to recruit for current and future studies in research on autism and other neurodevelopmental disabilities.

Aim 1: to recruit people interested in research on autism and other neurodevelopmental disabilities

Aim 2: to complete a diagnostic assessment, to confirm the diagnosis of autism spectrum disorder or other developmental disability (e.g., developmental language delay) in our patient population and rule out a diagnosis of autism spectrum disorder and other comorbid conditions in our control group

Aim 3: to maintain subject information in a database, from which we can recruit for our studies

Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Adult/Pediatric

  • Autism Spectrum Disorder
  • Developmental Language Disorders
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
5000
January 2014
January 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Enrollment will be open to typically-developing, healthy children and adults (ages 0-45), children and adults with autism spectrum disorder (ages 0-45), siblings of children and adults with autism spectrum disorder (ages 0-45), and children and adults with developmental language delays (ages 0-45).
Both
up to 45 Years
Yes
Contact: Manuel Zetino, Rsch Coord 617-766-9766 TRANSCEND@partners.org
United States
 
NCT00549731
2007-P-000062
No
Martha Herbert, Massachusetts General Hospital
Massachusetts General Hospital
Not Provided
Principal Investigator: Martha Herbert, MD, Ph.D Massachusetts General Hospital
Principal Investigator: Tal Kenet, Ph.D Massachusetts General Hospital
Principal Investigator: Katherine Martien, MD Massachusetts General Hospital/LADDERS
Massachusetts General Hospital
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP